Toxic Epidermal Necrolysis/Stevens-Johnson Syndrome at a University Hospital in Saudi: Causative Factors and Outcomes

被引:0
|
作者
Kokandi, Amal A. [1 ,2 ]
机构
[1] King Abdulaziz Univ, Fac Med, Dept Dermatol, Jeddah, Saudi Arabia
[2] King Abdulaziz Univ Hosp, Jeddah, Saudi Arabia
关键词
Stevens-Johnson syndrome; Toxic epidermal necrolysis; Drug reaction; PATIENT; DRUGS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) are rare, life-threatening conditions caused mainly by drugs. Their management relies on the withdrawal of the culprit medication and supportive measures. Different pharmacotherapies have varied effects. However, data related to TEN and SJS in Saudi is limited. Objective: This study aimed to identify the causative agents, associated factors, and outcomes of TEN/SJS cases admitted to a teaching hospital (King Abdulaziz University) in Jeddah during the last 10 years. Methods: retrospective descriptive study. The data of patients admitted to the King Abdulaziz University hospital with TEN/SJS diagnosis over the last 10 years were collected Result: We identified 12 patients with TEN/SJS. Of these, nine survived the condition and were discharged. The culprit medication was identified in eight of them, including antibiotics in six cases and Tegretol and allopurinol in one case each. Most of the patients received systemic steroids and intravenous immunoglobulins. Conclusion: TEN/SJS is mainly caused by medications of which antibiotics are the most implicated. Consistent with other studies, the mortality rate associated with TEN/SJS in Saudi is 25%. Limitations: restricted to a single center and small sample size.
引用
收藏
页码:1129 / 1132
页数:4
相关论文
共 50 条
  • [21] Ocular manifestation, complications and aetiological factors in Stevens-Johnson syndrome/toxic epidermal necrolysis
    Chhipa, Shaukat Ali
    Masood, Sadia
    Salarzai, Yasir
    Khan, Qazi Assad
    Ahmad, Khabir
    Sajid, Sara
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2015, 65 (01) : 62 - 64
  • [22] Readmission Risk Factors and Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Jiang, Yiran
    Sharpe, Tyler
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (04)
  • [23] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Pediatric Population A Review
    Alerhand, Stephen
    Cassella, Courtney
    Koyfman, Alex
    PEDIATRIC EMERGENCY CARE, 2016, 32 (07) : 472 - 476
  • [24] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Evaluation
    Dicle, Oezlem
    Yilmaz, Ertan
    Alpsoy, Erkan
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2009, 43 (01): : 15 - 20
  • [25] Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Chronopoulos, A.
    Pleyer, U.
    Mockenhaupt, M.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 534 - 539
  • [26] Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
    Fagot, JP
    Mockenhaupt, M
    Bouwes-Bavinck, JN
    Naldi, L
    Viboud, C
    Roujeau, JC
    AIDS, 2001, 15 (14) : 1843 - 1848
  • [27] Wound Management in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Jaller, Jose A.
    McLellan, Beth N.
    Balagula, Yevgeniy
    CURRENT DERMATOLOGY REPORTS, 2020, 9 (01) : 58 - 72
  • [28] A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Abulatan, Isaac T.
    Ben-David, Sage G.
    Morales-Colon, Lery A.
    Beason, Elisabeth
    Fakoya, Adegbenro O.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [29] Stevens-Johnson syndrome/toxic epidermal necrolysis in a child
    Jun, M. Tichy
    Karlova, I.
    Sen, M. Tichy
    Urbanek, J.
    Ditrichova, D.
    ALLERGOLOGIE, 2011, 34 (05) : 264 - 267
  • [30] Stevens-Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
    Vivar, Karina L.
    Mancl, Kimberly
    Seminario-Vidal, Lucia
    CLINICAL CASE REPORTS, 2018, 6 (02): : 258 - 261